Hematopoietic stem cell dysfunction in traumatic brain injury and alzheimer's disease
Active Project Grant Awarded Last action
- Award ID
- F31NS139434
- Recipient
-
Case Western Reserve University UEI HJMKEF7EJW69
- Awarding agency
-
National Institute of Neurological Disorders and Stroke
National Institutes of Health, Department of Health and Human Services
- Obligated
- $212,600
Award facts
- Assistance listing
- 93.853 Extramural Research Programs in the Neurosciences and Neurological Disorders
- Completion date 69% complete
- Place of performance
- Cleveland, OH 44106, USA
Award details come from USAspending.gov.
Description
- Abstract
- Traumatic brain injury (TBI) is the greatest environmental risk factor for alzheimer's disease (ad). Although both neurological conditions share many of the same pathological hallmarks including neurodegeneration, the underlying mechanisms that establish this relationship between TBI and ad are not well understood. Acute TBI transitions into chronic TBI, which is characterized by progressive neurodegeneration. The pathophysiologic events associated with the transition of acute TBI into a chronic neurodegenerative condition can last for months, years, or even a lifetime and are also thought to be associated with the pathogenesis of ad after TBI. Investigating the mechanistic link between acute TBI, chronic TBI, and ad is important as there are currently no therapeutic strategies to protect patients. My proposed interdisciplinary project aims to address this knowledge GAP by assessing the interplay between TBI, hematopoietic stem cell (HSC) dysfunction, chronic neurodegeneration, and ad. Specifically, i am testing the novel hypothesis that acute TBI induces changes to hscs that in turn play a role in impairing the immune system and propagating chronic neurodegeneration after TBI, and that these TBI-induced alterations are related to the increased risk of ad after TBI. Hscs generate the entire spectrum of blood and immune cells, and my preliminary studies thus far indicate that TBI induces major changes to hscs, including impaired HSC function, disrupted blood cell counts, and elevated inflammatory markers. This study employs a clinically relevant model of TBI, cytometric analyses, and immunohistochemical approaches to generate a deeper understanding of hematopoietic dysfunction in TBI and ad and the implications of this dysfunction on the immune system and chronic neurodegeneration. Furthermore, this proposal is tailored for a physician-scientist in training as IT investigates the underlying mechanisms by which acute TBI transitions into a chronic neurodegenerative condition, with implications for novel therapeutic targets for reducing neurodegeneration after TBI and protecting TBI patients from developing ad.
Transactions
| Action | Obligated | Date |
|---|---|---|
| Amendment | $55,114 | |
| Amendment | $54,538 | |
| Amendment | $5,000 | |
| Amendment | $48,974 | |
| Original award | $48,974 |
Quick answers
Who received award F31NS139434?
F31NS139434 was awarded to Case Western Reserve University by National Institute of Neurological Disorders and Stroke (National Institutes of Health) on December 1, 2024.
How much is award F31NS139434 worth?
$212,600 has been obligated on F31NS139434.
On GovTribe
See this award's full record
- Every transaction and subaward
- The recipient's other awards and teaming partners
- Similar grant awards
- Ask GovTribe AI about this award